Document is current
Any future updates will be listed below
-
Authors
Bergamini, Christian
Leoni, Ilaria
Rizzardi, Nicola
Melli, Mattia
Galvani, Giuseppe
Coada, Camelia Alexandra
Giovannini, Catia
Monti, Elisa
Liparulo, Irene
Valenti, Francesca
Ferracin, Manuela
Ravaioli, Matteo
Cescon, Matteo
Vasuri, Francesco
Piscaglia, Fabio
Negrini, Massimo
Stefanelli, Claudio
Fato, Romana
Gramantieri, Laura
Fornari, Francesca http://orcid.org/0000-0002-4302-4411
-
Funding
Funding for this research was provided by:
Fondazione AIRC per la Ricerca sul Cancro (IG-25187)
University of Bologna (Alma Idea 2022)
Regione Emilia-Romagna (Innovative approaches to the diagnosis, pharmacogenetics-based therapies of primary hepatic tumors, peripheral B, T-cell lymphomas, lymphoblastic leukaemias)
Ministero dell’Istruzione, dell’Università e della Ricerca (PNRR - M4C2-I1.3 Project PE_00000019 "HEAL ITALIA")
- License Information
-
More Information
Article History
Received: 17 February 2023
Accepted: 22 May 2023
First Online: 10 June 2023
Declarations
:
: The Ethics Committee of S.Orsola-Malpighi Hospital (138/2015/O/Tess and 271/2012/O/Oss) approved this study. The protocols for animal experimentation were approved by local Ethics Committee of Bologna University (xenograft mice, protocol N. 23–79-2014) and by Italian Minister of Health (DEN-HCC rats, protocol N.421/2016-PR).
: All authors have agreed to publish this manuscript.
: The authors declare no competing interests.
